Bookmark! (press Ctrl+D)

In this UCSF Medicine Covid-19 grand rounds, we’ll explore the extraordinarily promising news regarding the Pfizer and Moderna vaccines, and what the future may hold in terms of FDA approval, distribution, and impact on the shape of the pandemic in 2021. In addition, we’ll also take a close look at a few of the therapeutics in the news, including monoclonal antibodies (one of which was just approved by the FDA for emergency use) and remdesivir (whose use has now become controversial based on recent trials). The session is moderated by UCSF Department of Medicine chair Bob Wachter.

Program
Bob Wachter: Introduction
00:04:03-0:41:55 – Vaccines: Paul Offit, Professor and Director of the Vaccine Education Center, Division of Infectious Diseases, Children’s Hospital of Philadelphia; Professor of Vaccinology, University of Pennsylvania
00:41:58-01:13:48 – Therapeutics: Annie Luetkemeyer, UCSF Professor of Medicine, Division of HIV, ID and Global Medicine at ZSFG
Bob Wachter: Closing

See previous Covid-19 Medical Grand Rounds:
• November 5: A Conversation with Kirsten Bibbins-Domingo, Ezekiel Emanuel, and Andy Slavitt: The Implications of the Election on the Future of the Pandemic

• October 22: The Third Wave, the View from Wisconsin, & Navigating Risk in Covid-19

• October 6: President Trump’s Covid-19 Diagnosis: Implications for Transmission, Treatment, and Prognosis

• September 24: San Francisco and Covid-19: What Went Right and Lessons Learned

See all UCSF Covid-19 grand rounds, which have been viewed over 1.2M times, here: https://medicine.ucsf.edu/covid-19-news-coverage

source

LEAVE A REPLY

Please enter your comment!
Please enter your name here